BR112019003232A2 - compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção - Google Patents

compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção

Info

Publication number
BR112019003232A2
BR112019003232A2 BR112019003232A BR112019003232A BR112019003232A2 BR 112019003232 A2 BR112019003232 A2 BR 112019003232A2 BR 112019003232 A BR112019003232 A BR 112019003232A BR 112019003232 A BR112019003232 A BR 112019003232A BR 112019003232 A2 BR112019003232 A2 BR 112019003232A2
Authority
BR
Brazil
Prior art keywords
compounds
beta
amide compounds
amino
obtaining
Prior art date
Application number
BR112019003232A
Other languages
English (en)
Inventor
M Sturdivant Jill
A Delong Mitchell
M Royalty Susan
Original Assignee
Aerie Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aerie Pharmaceuticals Inc filed Critical Aerie Pharmaceuticals Inc
Publication of BR112019003232A2 publication Critical patent/BR112019003232A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

divulga-se a presente invenção de compostos de amida alfa-axil-beta-axmno isoquinolina e compostos de benzamida substituídos. em particular, a invenção fornece compostos que afetam a função de cinases em uma célula e que são úteis como agentes terapêuticos ou com agentes terapêuticos. os compostos da invenção são úteis no tratamento de uma variedade de doenças e condições incluindo doenças oculares tais como glaucoma, doenças cardiovasculares e doenças caracterizadas pelo crescimento anormal, tais como cânceres. a invenção fornece ainda composições contendo compostos de isoquinolina amida.
BR112019003232A 2016-08-19 2017-03-31 compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção BR112019003232A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662377219P 2016-08-19 2016-08-19
PCT/US2017/025609 WO2018034702A1 (en) 2016-08-19 2017-03-31 Beta-amino-isoquinolinyl amide compounds

Publications (1)

Publication Number Publication Date
BR112019003232A2 true BR112019003232A2 (pt) 2019-06-18

Family

ID=61191217

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019003232A BR112019003232A2 (pt) 2016-08-19 2017-03-31 compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção

Country Status (10)

Country Link
US (1) US9963432B2 (pt)
EP (1) EP3500251A4 (pt)
JP (1) JP2019529359A (pt)
KR (1) KR20190039587A (pt)
CN (1) CN109640971A (pt)
AU (1) AU2017312712B2 (pt)
BR (1) BR112019003232A2 (pt)
CA (1) CA3033184C (pt)
MX (1) MX2019002019A (pt)
WO (1) WO2018034702A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
JP2012525386A (ja) 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
CN109528721B (zh) 2013-03-15 2021-10-01 爱瑞制药公司 联合治疗
KR102568082B1 (ko) 2016-08-31 2023-08-17 에어리 파마슈티컬즈, 인코포레이티드 안과용 조성물
AU2018243687C1 (en) 2017-03-31 2020-12-24 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
SG11202009246UA (en) * 2018-03-30 2020-10-29 Aerie Pharmaceuticals Inc Mono-(acid) salts of 6-aminoisoquinolines and uses thereof
SG11202101517PA (en) * 2018-08-31 2021-03-30 Aerie Pharmaceuticals Inc Isoquinoline-steroid conjugates and uses thereof
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2021001713A1 (en) * 2019-06-29 2021-01-07 Micro Labs Limited Process for the preparation of (s)-netarsudil, its salts & polymorphs
TWI777325B (zh) * 2019-12-31 2022-09-11 財團法人工業技術研究院 β-胺基酸衍生物、含其之激酶抑制劑與醫藥組成物以及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455513B2 (en) * 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) * 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
JP2012525386A (ja) * 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
CN109528721B (zh) * 2013-03-15 2021-10-01 爱瑞制药公司 联合治疗
US9643927B1 (en) * 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US10550087B2 (en) * 2015-11-17 2020-02-04 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof

Also Published As

Publication number Publication date
JP2019529359A (ja) 2019-10-17
WO2018034702A1 (en) 2018-02-22
MX2019002019A (es) 2019-07-04
CN109640971A (zh) 2019-04-16
US9963432B2 (en) 2018-05-08
CA3033184C (en) 2024-06-04
US20180050990A1 (en) 2018-02-22
CA3033184A1 (en) 2018-02-22
EP3500251A1 (en) 2019-06-26
AU2017312712B2 (en) 2019-12-12
KR20190039587A (ko) 2019-04-12
AU2017312712A1 (en) 2019-02-21
EP3500251A4 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
BR112019003232A2 (pt) compostos de beta-amino-isoquinolinil amida, composições que o incluem e métodos de obtenção
CO2019006622A2 (es) Derivados de pirazol como inhibidores de malt1
MX2019011784A (es) Compuestos de aril ciclopropil-amino-isoquinolinil amida.
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
BR112018074185A2 (pt) 3-oxo-2,6-difenil-2,3-di-hidropiridazina-4-carboxamidas
BR112018017172A2 (pt) anticorpos monoclonais anti-alfa-sinucleína para prevenção da agregação de tau
CO2019008684A2 (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas para el tratamiento del cancer
EA201692177A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
BR112018003264A2 (pt) conjugados de aldeído e usos dos mesmos
BR112018003250A2 (pt) compostos deuterados e usos dos mesmos
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201791874A1 (ru) Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение
EA201891539A1 (ru) Соединения, ингибирующие металлоферменты
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
BR112015028879A2 (pt) derivados heterocíclicos
JO3316B1 (ar) مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل
MX363457B (es) Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1).
BR112018012981A2 (pt) derivados do ácido meta-azacíclico amino benzoico como antagonistas de pan integrina com melhores propriedades farmacocinéticas
MX2018016419A (es) Derivados de n-(sustituida-fenil)-sulfonamida como inhibidores de quinasa n-(sustituida-fenil)-sulfonamida.
EA201990400A1 (ru) Соединения и композиции и их применение
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
CO2019002889A2 (es) Tratamientos de combinación que comprenden la administración de imidazopirazinonas
EA202091020A1 (ru) Замещенные имидазопиридинамиды и их применение
EA201791367A1 (ru) Соединения 2,3,4,5-тетрагидропиридин-6-амин и 3,4-дигидро-2h-пиррол-5-амин - ингибиторы бета-секретазы
EA202090414A1 (ru) Соединения и их применение

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]